Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Quan Zheng(Shanghai Jiao Tong University), Christopher Heeschen(Candiolo Cancer Institute)
Cited by 16
Related Papers
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
|Circulation|2003|1k
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
|Gut|2018|147
Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation
|Stem Cells|2015|39
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
|Journal of Visualized Experiments|2015|27
Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesis
|Journal of Clinical Investigation|2025|5